## Why option 1 is correct The India ink negative stain (shown at **D**) works because the large polysaccharide capsule (composed of glucuronoxylomannan, GXM) of *Cryptococcus neoformans* is hydrophilic and excludes the India ink dye. This creates a characteristic clear halo around the yeast cell against a black background — the pathognomonic feature for cryptococcal identification in CSF. This is the classic microscopic finding in cryptococcal meningitis, especially in advanced HIV with CD4 < 100/μL, and the capsule itself is the major virulence factor (anti-phagocytic and immunosuppressive). The India ink method achieves 60–80% sensitivity in HIV patients with CNS disease and remains a rapid, inexpensive bedside diagnostic tool in resource-limited Indian settings. ## Why each distractor is wrong - **Option 2**: India ink is a negative stain that does NOT penetrate the cell; it stains the background, not the organism. Melanin visualization requires Fontana-Masson staining, not India ink. This is a fundamental misunderstanding of negative staining principle. - **Option 3**: While narrow-based budding is indeed a morphologic feature of *Cryptococcus*, it is NOT the reason India ink is useful. Narrow-based budding is better visualized with GMS or H&E staining, not India ink. The diagnostic utility of India ink is entirely due to capsule exclusion of dye. - **Option 4**: India ink is a morphologic stain, not a serologic test. Serologic confirmation requires cryptococcal antigen (CrAg) latex agglutination or lateral flow assay on serum or CSF — these are separate diagnostic modalities with > 95% sensitivity and are not performed with India ink. **High-Yield:** India ink negative stain → clear halo = *Cryptococcus* capsule excludes dye; classic CSF finding in HIV meningitis; 60–80% sensitive but rapid and inexpensive. [cite: Murray Microbiology 9e; Harrison 21e Ch 215]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.